相关实验视频

Updated: Jul 26, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

向C5a补充剂,以改善非小细胞肺癌的放射治疗灵敏度

Meng Yuan¹, Chenlin Wang^2,3, Yanan Wu^3,4

¹Department of Oncology, Shandong Provincial Qianfoshan Hospital, Weifang Medical University, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China.

Translational lung cancer research

|June 16, 2023

概括

通过阻断C5a/C5aR1信号传递,可以克服肺癌中放射治疗 (RT) 的耐药性. 将RT与C5aR1抑制剂结合,可以增强抗瘤免疫力,改善治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
辐射疗法辐射疗法

背景情况:

放射治疗 (RT) 耐药性和瘤复发是癌症治疗中的重大挑战.
免疫系统,包括先天性和适应性组成部分,在RT的抗瘤作用中起着至关重要的作用.
补充C5a/C5aR1信号影响瘤微环境 (TME) 并可能影响RT疗效.

研究的目的:

为了研究补充C5a/C5aR1信号在TME中在RT之后的作用.
探索将RT与C5aR1抑制相结合的潜力,以克服放射电阻.
阐明RT诱导免疫调节的潜在分子机制.

主要方法:

给易斯肺癌 (LLC) 瘤携带的小鼠进行分离RT.
在RT治疗瘤中分析了CD8+T细胞透和基因表达.
在接受RT和/或C5aR1抑制剂治疗的小鼠中评估瘤生长和免疫反应.
在被辐射的组织中评估C5a/C5aR1表达和AKT/NF-κB通路激活.

主要成果:

RT增加了CD8+T细胞的透,并激活了局部补充C5a/C5aR信号传递.
结合RT和C5aR1阻断增强了辐射敏感性和抗瘤免疫反应.
在CD8+T细胞上高C5aR1表达与改善的结果相关.
鉴定出AKT/NF-κB通路是RT中C5a/C5aR信号传递的关键媒介.

结论:

RT诱导瘤细胞释放C5a,通过AKT/NF-κB通路上调C5aR1.
抑制C5a-C5aR1相互作用可以改善RT敏感性和抗瘤作用.
结合RT和C5aR1阻断的联合治疗为改善肺癌治疗提供了一个有前途的策略.

关键词:

放射治疗 (RT) 是一种疗法.补充剂 C5a 的情况.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.无线电电阻的使用方法辐射敏感性辐射敏感性

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...